Company Filing History:

13 out of 45

Vivus, Inc.

The United States of America As Represented by the Department of Health

patents

4. 1 out of 3,435

National Institutes of Health, a Component of the US Dept. of Health & Human Services

patents

where one patent can have more than one assignee

Years Active: 1999-2003

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6593313 - Co-administration of a prostaglandin and an androgenic agent in the treatment of female sexual dysfunction (2003-07-15),

2. 6548490 - Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction (2003-04-15),

3. 6472434 - Method for minimizing excess collagen deposition (2002-10-29),

4. 6469016 - Treatment of female sexual dysfunction using phosphodiesterase inhibitors (2002-10-22),

5. 6403597 - Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation (2002-06-11),

6. 6306841 - Treatment of female sexual dysfunction (2001-10-23),

7. 6294550 - Treatment of female sexual dysfunction (2001-09-25),

8. 6290981 - Use of nitric oxide-releasing agents to treat impotency (2001-09-18),

9. 6228864 - Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation (2001-05-08),

10. 6156753 - Local administration of type III phosphodiesterase inhibitors for the (2000-12-05),

11. 6127363 - Local administration of Type IV phosphodiesterase inhibitors for the (2000-10-03),

12. 6037360 - Administration of 5-HT.sub.3 receptor antagonists to treat premature (2000-03-14),

13. 6037346 - Local administration of phosphodiesterase inhibitors for the treatment (2000-03-14),

14. 5919474 - Transurethral administration of vasoactive agents to treat peripheral (1999-07-06),

15. 5910316 - Use of nitric oxide-releasing agents to treat impotency (1999-06-08),

Title: The Innovative Mind of Paul C Doherty, Jr.

Introduction

Paul C Doherty, Jr. is a noteworthy inventor based in Cupertino, California, who has made significant contributions to the field of pharmaceuticals, particularly in addressing sexual dysfunction. With 16 patents to his name, his work showcases innovative approaches to treatment that combine both scientific rigor and practical application.

Latest Patents

Doherty's latest patents include groundbreaking methods and formulations for treating female sexual dysfunction. One prominent patent details the co-administration of a prostaglandin and an androgenic agent, highlighting an effective pharmaceutical composition aimed at enhancing sexual health in women. This approach utilizes vasoactive agents administered to the vagina, vulvar area, or urethra, featuring various options such as vasodilators, smooth muscle relaxants, and leukotriene inhibitors. This innovative formulation not only aims to improve sexual function but is also noted for its potential to prevent yeast infections, enhance vaginal lubrication, and improve tissue health.

Another significant patent addresses the treatment of erectile dysfunction through the transmucosal administration of phosphodiesterase inhibitors. This method provides a novel approach by allowing for administration via transbuccal, sublingual, or transrectal routes within an effective dosage regimen, thus broadening the options available for patients suffering from this condition. The accompanying pharmaceutical formulations and kits further illustrate his commitment to creating accessible solutions.

Career Highlights

Doherty has worked with renowned companies such as Vivus, Inc. and Asivi, LLC, where he played an integral role in developing these innovative therapies. His career has been marked by a strong focus on pharmaceutical development and a passion for improving the quality of life for individuals facing sexual dysfunction.

Collaborations

Throughout his career, Doherty has collaborated with notable figures in the industry, including Virgil A Place and Mark S Hanamoto. These partnerships have allowed him to enhance his research and development efforts, further contributing to his many patents and innovations.

Conclusion

Paul C Doherty, Jr.'s contributions to the field of pharmaceutical science demonstrate his dedication to innovation and improvement in medical treatments. With a strong portfolio of patents focused on sexual dysfunction, he continues to make significant strides in enhancing the quality of life for many individuals. His work not only underscores his technical expertise but also reflects a deep commitment to addressing complex medical issues through inventive solutions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.